Terns Phar­ma­ceu­ti­cal­s' CEO Senthil Sun­daram steps down for health rea­sons

Terns Phar­ma­ceu­ti­cals CEO Senthil Sun­daram has re­signed from his po­si­tion for health rea­sons.

Terns dis­closed in an SEC fil­ing in Jan­u­ary of last year that Sun­daram had re­ceived a can­cer di­ag­no­sis and would “un­der­go ag­gres­sive treat­ment, in­clud­ing chemother­a­py.” At the time, Sun­daram planned to main­tain his du­ties as CEO dur­ing treat­ment, but would “lim­it cer­tain busi­ness ac­tiv­i­ties, in­clud­ing trav­el.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER